SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 424B5 - Prospectus [Rule 424(b)(5)]:
SEC Accession No. 0001104659-21-020808
Filing Date
2021-02-11
Accepted
2021-02-11 17:14:38
Documents
5

Document Format Files

Seq Description Document Type Size
1 424B5 tm214090d1_424b5.htm 424B5 782066
2 GRAPHIC tm214090d1_424b5img001.jpg GRAPHIC 6516
3 GRAPHIC tm214090d1_424b5img003.jpg GRAPHIC 99767
4 GRAPHIC tm214090d1_424b5img005.jpg GRAPHIC 5821
5 GRAPHIC tm214090d1_424b5img007.jpg GRAPHIC 79516
  Complete submission text file 0001104659-21-020808.txt   1047559
Mailing Address 863 MITTEN ROAD SUITE 102 BURLINGAME CA 94010
Business Address 863 MITTEN ROAD SUITE 102 BURLINGAME CA 94010 (650) 900-4520
Corvus Pharmaceuticals, Inc. (Filer) CIK: 0001626971 (see all company filings)

IRS No.: 464670809 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 424B5 | Act: 33 | File No.: 333-237040 | Film No.: 21620915
SIC: 2834 Pharmaceutical Preparations